Identification of Signal of Clindamycin Associated Renal Failure Acute: A Disproportionality Analysis
Author:
Affiliation:
1. Department of Clinical Research, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi, 110017, India
2. Department of Pharmacology, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi, 110017, India
Abstract
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference21 articles.
1. World health organization. Quality Assurance and Safety of Medicines Team. Safety of Medicines. Aguide to delicting and report adverse durg reaction, Wht health professionals need to take action. WHO 2002
2. Subeesh V.; Singh H.; Maheswari E.; Beulah E.; Novel adverse events of vortioxetine: A disproportionality analysis in USFDA adverse event reporting system database. Asian J Psychiatr 2017,30,152-156
3. Sharma A.; Kumar A.; Identification of novel signal of clobazam‐associated drug reaction with eosinophilia and systemic symptoms syndrome: A disproportionality analysis. Acta Neurol Scand 2022,146(5),623-627
4. Spížek J.; Řezanka T.; Lincomycin, clindamycin and their applications. Appl Microbiol Biotechnol 2004,64(4),455-464
5. Summary of product characteristics (SmPC) of clindamycin. Electronic Medicines Compendium. Available from: [Accessed on: 30th Sep 2021].
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Exploring the top 30 drugs associated with drug-induced constipation based on the FDA adverse event reporting system;Frontiers in Pharmacology;2024-09-02
2. Antihypertensive drug-associated adverse events in osteoarthritis: a study of a large real-world sample based on the FAERS database;Frontiers in Pharmacology;2024-09-02
3. Safety of immune checkpoint inhibitors: An updated comprehensive disproportionality analysis and meta-analysis;Critical Reviews in Oncology/Hematology;2024-08
4. Infection associated with CDK4/6 inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system database;Frontiers in Pharmacology;2024-07-01
5. A real-world data analysis of tirzepatide in the FDA adverse event reporting system (FAERS) database;Frontiers in Pharmacology;2024-06-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3